Short- and long-term effect of high versus low-to-moderate intensity exercise to optimise health-related quality of life after oncological treatment-results from the Phys-Can project

被引:7
|
作者
Ax, Anna-Karin [1 ,2 ]
Johansson, Birgitta [3 ]
Lyth, Johan [1 ,2 ]
Nordin, Karin [4 ]
Borjeson, Sussanne [1 ,2 ]
机构
[1] Linkoping Univ, Dept Oncol, Linkoping, Sweden
[2] Linkoping Univ, Dept Hlth Med & Caring Sci, Linkoping, Sweden
[3] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden
[4] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden
基金
瑞典研究理事会;
关键词
Cancer; Oncological treatment; Exercise; HRQoL; EUROPEAN-ORGANIZATION; BREAST-CANCER; FOLLOW-UP; FATIGUE; QUESTIONNAIRE; METAANALYSIS; CHEMOTHERAPY; INSTRUMENT; GUIDELINES; SURVIVORS;
D O I
10.1007/s00520-022-07016-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose This study aimed to evaluate the effect of high intensity (HI) vs low-to-moderate intensity (LMI) exercise on health-related quality of life (HRQoL) up to 18 months after commencement of oncological treatment in patients with breast, colorectal or prostate cancer. In addition, we conducted a comparison with usual care (UC). Methods Patients scheduled for (neo)adjuvant oncological treatment (n = 577) were randomly assigned to 6 months of combined resistance and endurance training of HI or LMI. A longitudinal descriptive study (UC) included participants (n = 89) immediately before the RCT started. HRQoL was assessed by EORTC QLQ-C30 at baseline, 3, 6 and 18 months (1 year after completed exercise intervention) follow-up. Linear mixed models were used to study the groups over time. Results Directly after the intervention, HI scored significant (P = 0.02), but not clinically relevant, higher pain compared with LMI. No other significant difference in HRQoL was found between the exercise intensities over time. Clinically meaningful improvements in HRQoL over time were detected within both exercise intensities. We found favourable significant differences in HRQoL in both exercise intensities compared with UC over time. Conclusion This study adds to the strong evidence of positive effect of exercise and shows that exercise, regardless of intensity, can have beneficial effects on HRQoL during oncological treatment and also for a substantial time after completion of an exercise intervention. In this study, for one year after. Implications for cancer survivors Patients can be advised to exercise at either intensity level according to their personal preferences, and still benefit from both short-term and long-term improvements in HRQoL.
引用
收藏
页码:5949 / 5963
页数:15
相关论文
共 15 条
  • [11] Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of life
    Smeland, Knut
    Holte, Harald
    Fagerli, Unn-Merete
    Bersvendsen, Hanne
    Hjermstad, Marianne J.
    Loge, Jon H.
    Murbrach, Klaus
    Linnsund, Marianne D.
    Fluge, Oystein
    Stenehjem, Jo S.
    Lund, May B.
    Kvaloy, Stein
    Kiserud, Cecilie E.
    HAEMATOLOGICA, 2022, 107 (11) : 2698 - 2707
  • [12] Age-specific health-related quality of life in disease-free long-term prostate cancer survivors versus male population controls-results from a population-based study
    Adam, Salome
    Doege, Daniela
    Koch-Gallenkamp, Lena
    Thong, Melissa S. Y.
    Bertram, Heike
    Eberle, Andrea
    Holleczek, Bernd
    Pritzkuleit, Ron
    Waldeyer-Sauerland, Mechthild
    Waldmann, Annika
    Zeissig, Sylke Ruth
    Jansen, Lina
    Rohrmann, Sabine
    Brenner, Hermann
    Arndt, Volker
    SUPPORTIVE CARE IN CANCER, 2020, 28 (06) : 2875 - 2885
  • [13] Health-Related Quality of Life and Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment With Multimatrix Mesalamine: A Prospective, Open-Label Study
    Yarlas, Aaron
    D'Haens, Geert
    Willian, Mary Kaye
    Teynor, Megan
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (02) : 450 - 463
  • [14] Long-term health-related quality of life of breast cancer survivors remains impaired compared to the age-matched general population especially in young women. Results from the prospective controlled BREX exercise study
    Roine, Eija
    Sintonen, Harri
    Kellokumpu-Lehtinen, Pirkko-Liisa
    Penttinen, Heidi
    Utriainen, Meri
    Vehmanen, Leena
    Huovinen, Riikka
    Kautiainen, Hannu
    Nikander, Riku
    Blomqvist, Carl
    Hakamies-Blomqvist, Liisa
    Saarto, Tiina
    BREAST, 2021, 59 : 110 - 116
  • [15] Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): long-term, health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial
    Buehrer, Emanuel
    Kicinski, Michal
    Mandala, Mario
    Pe, Madeline
    Long, Georgina, V
    Atkinson, Victoria
    Blank, Christian U.
    Haydon, Andrew
    Dalle, Stephane
    Khattak, Adnan
    Carlino, Matteo S.
    Meshcheryakov, Andrey
    Sandhu, Shahneen
    Puig, Susana
    Schadendorf, Dirk
    Jamal, Rahima
    Rutkowski, Piotr
    van den Eertwegh, Alfonsus J. M.
    Coens, Corneel
    Grebennik, Dmitri
    Krepler, Clemens
    Robert, Caroline
    Eggermont, Alexander
    LANCET ONCOLOGY, 2024, 25 (09) : 1202 - 1212